About Bevacizumab injection
Bevacizumab is a humanized IgG1 monoclonal antibody that binds to and neutralizes vascular endothelial growth factor (VEGF), effectively inhibiting the
formation of new blood vessels (angiogenesis) that tumors need to grow and spread. It is used in various solid tumors, including metastatic colorectal cancer,
non-small cell lung cancer, glioblastoma, renal cell carcinoma, ovarian, fallopian tube, primary peritoneal, cervical, and hepatocellular cancer. Administered
intravenously, bevacizumab is typically combined with chemotherapy agents to enhance anti-tumor activity and improve progression-free and overall survival.
Key Features and CompositionThis Bevacizumab injection comes in a stable liquid salt composition, formulated for both IM and IV routes. The product is carefully manufactured to ensure efficacy and safety for adult patients. Its physical characteristics and normal fermentation odor underscore its pharmaceutical-grade quality, making it a reliable choice for healthcare providers.
Proper Storage and HandlingTo maintain its potency and integrity, Bevacizumab injection should be stored at standard refrigeration or room temperatures between 2C and 25C. Adhering to appropriate storage guidelines ensures the formulation remains viable throughout its shelf life of 700 days. Always check the packaging for storage instructions before use.
Intended Usage and ApplicationThis liquid injection is prescribed for adults over 18 years and is meant for administration either intravenously or intramuscularly. Healthcare professionals should supervise its use, ensuring the correct dosage and method of administration for optimal therapeutic benefit.
FAQ's of Bevacizumab injection:
Q: How should Bevacizumab injection be stored to retain its effectiveness?
A: Bevacizumab injection must be stored at a temperature range between 2C and 25C. Keeping it within these conditions preserves the active ingredients and prolongs its shelf life to approximately 700 days.
Q: What is the recommended usage of this injection?
A: This injection is intended for adults above 18 years, primarily administered intravenously (IV) or intramuscularly (IM) by a trained healthcare provider. The specific dosage and treatment regimen depend on the medical condition being addressed.
Q: When is Bevacizumab injection typically indicated?
A: Bevacizumab injection is usually prescribed for certain medical conditions as evaluated and determined appropriate by a healthcare professional. Always use this medication under professional supervision and follow their recommendations.
Q: Where is this product manufactured and supplied from?
A: The product is sourced from India and distributed by exporters, suppliers, traders, and wholesalers, making it accessible for international and local pharmaceutical markets.
Q: What process is involved in maintaining the product's quality during storage?
A: Quality is maintained by storing Bevacizumab injection at controlled temperatures of 2C to 25C and ensuring it is kept in its original packaging to avoid contamination and potency loss.
Q: What benefits can users expect from Bevacizumab injection?
A: When administered as directed by a healthcare professional, this injection can provide therapeutic benefits for the indicated conditions, supporting targeted treatment and improving patient outcomes.